Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (CHTP) was an early-stage venture capital firm specializing in the healthcare and life sciences sectors. Established in 1998 as a consulting and merchant banking firm, it transitioned to venture capital in 2000, focusing on innovative technology applications in medicine and biotechnology. The firm was a predecessor to Catalyst Health Ventures (CHV) and played a key role in the early funding of companies such as Novazyme Pharmaceuticals, BioTrove, and Biocius Life Sciences. CHTP primarily invested in the Northeastern United States, particularly the Greater Boston area, before its operations were integrated into the successor fund. The firm's investment strategy targeted high-growth opportunities in medical technology, diagnostics, and drug discovery platforms.